Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat-dose antimicrobial photodynamic therapy for acne vulgaris on the upper back
2010-018313-29Phase 2Terminated
- Sponsor
- Photopharmica
- Start
- Mar 2010
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of PPA-904 in acne vulgaris, sponsored by Photopharmica. Primary endpoint: Change in total lesion count at 12 weeks. Started Mar 2010; status: terminated.
02
Drugs
PPA-904
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2010-018313-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018313-29.